We are live on !
Find out more
LP
LGL Partners Portfolio holdings
AUM
$273M
Turnover
24.66%
1-Year Est. Return
24.15%
This Fund
S&P 500
This Quarter Est. Return
+14.57%
1 Year Est. Return
+24.15%
3 Year Est. Return
+68.92%
5 Year Est. Return
+65.82%
10 Year Est. Return
+206.18%
AUM
$273M
AUM Growth
+$30.5M
(+13%)
Cap. Flow
-$2.74M
Cap. Flow % of AUM
Cap. Flow %
-1%
Top 10 Holdings %
Top 10 Hldgs %
80.4%
Holding
73
New
7
Increased
40
Reduced
6
Closed
11
Avg Time Held
4.4
years
Top 10 Avg Time Held
3.6
years
Top 20 Avg Time Held
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$550K |
| 2 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$502K |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$461K |
| 4 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$418K |
| 5 |
iShares Core High Dividend ETF
HDV
|
+$358K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.19M |
| 2 |
Liquidia Corp
LQDA
|
+$1.09M |
| 3 |
Coupang
CPNG
|
+$850K |
| 4 |
Sabra Healthcare REIT
SBRA
|
+$794K |
| 5 |
JPMorgan Chase
JPM
|
+$615K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 97.3% |
| 2 | Financials | 0.82% |
| 3 | Technology | 0.82% |
| 4 | Healthcare | 0.45% |
| 5 | Industrials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Global X MLP ETF
MLPA
$2.32B
| $967K | 0.35% |
18,215
+336
| +2% | +$18.1K |
2020 Q2
24 quarters
|
|
27
SPDR Gold Trust
GLD
$140B
| $827K | 0.3% |
2,245
| – | – |
2015 Q4
42 quarters
|
|
28
Microsoft
MSFT
$3.95T
| $803K | 0.29% |
2,154
+505
| +31% | +$204K |
2019 Q1
29 quarters
|
|
29
PTC Therapeutics
PTCT
$5.25B
| $734K | 0.27% |
9,000
| – | – |
2024 Q2
8 quarters
|
|
|
30
iShares Core High Dividend ETF
HDV
$15.7B
| $706K | 0.26% |
25,742
+13,162
| +105% | +$358K |
2026 Q1
1 quarter
|
|
31
iShares Russell 1000 Growth ETF
IWF
$126B
| $705K | 0.26% |
5,676
+4
| +0.1% | +$482 |
2019 Q1
29 quarters
|
|
32
Vanguard Total World Stock ETF
VT
$81.8B
| $657K | 0.24% |
4,184
+15
| +0.4% | +$2.29K |
2020 Q4
22 quarters
|
|
33
IBM
IBM
$228B
| $637K | 0.23% |
2,266
+152
| +7% | +$38.3K |
2025 Q1
5 quarters
|
|
|
34
Vanguard S&P 500 ETF
VOO
$1.04T
| $567K | 0.21% |
+825
| New | +$550K |
2026 Q2
0 quarters
|
|
|
35
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.9B
| $503K | 0.18% |
+9,939
| New | +$502K |
2026 Q2
0 quarters
|
|
36
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.5B
| $496K | 0.18% |
1,356
+1
| +0.1% | +$341 |
2022 Q4
14 quarters
|
|
37
VanEck Gold Miners ETF
GDX
$26.2B
| $491K | 0.18% |
6,511
-65
| -1% | -$5.74K |
2023 Q4
10 quarters
|
|
38
iShares MSCI Switzerland ETF
EWL
$2.92B
| $490K | 0.18% |
7,792
+135
| +2% | +$8.31K |
2025 Q2
4 quarters
|
|
39
Global Payments
GPN
$22.4B
| $484K | 0.18% |
6,673
+25
| +0.4% | +$1.72K |
2025 Q1
5 quarters
|
|
|
40
Vanguard Short-Term Corporate Bond ETF
VCSH
$43.9B
| $461K | 0.17% |
+5,838
| New | +$461K |
2026 Q2
0 quarters
|
|
41
iShares S&P 500 Value ETF
IVE
$50.2B
| $430K | 0.16% |
1,895
+7
| +0.4% | +$1.56K |
2020 Q4
22 quarters
|
|
42
Vanguard FTSE Europe ETF
VGK
$29.7B
| $415K | 0.15% |
4,685
+25
| +0.5% | +$2.19K |
2026 Q1
1 quarter
|
|
43
iShares ESG Optimized MSCI USA ETF
SUSA
$4.08B
| $388K | 0.14% |
2,515
+4
| +0.2% | +$591 |
2023 Q1
13 quarters
|
|
44
WisdomTree US AI Enhanced Value Fund
AIVL
$419M
| $381K | 0.14% |
2,909
-28
| -1% | -$3.48K |
2020 Q4
22 quarters
|
|
45
Vanguard Morningstar Growth ETF
VUG
$229B
| $377K | 0.14% |
4,371
+3
| +0.1% | +$252 |
2023 Q4
10 quarters
|
|
46
West Pharmaceutical
WST
$27.4B
| $374K | 0.14% |
1,041
+1
| +0.1% | +$306 |
2024 Q4
6 quarters
|
|
47
Apple
AAPL
$4.95T
| $311K | 0.11% |
1,073
| – | – |
2019 Q1
29 quarters
|
|
48
State Street Utilities Select Sector SPDR ETF
XLU
$24.5B
| $276K | 0.1% |
6,089
+39
| +0.6% | +$1.77K |
2024 Q2
8 quarters
|
|
49
iShares National Muni Bond ETF
MUB
$50.8B
| $274K | 0.1% |
2,545
+6
| +0.2% | +$642 |
2015 Q4
42 quarters
|
|
50
Trane Technologies
TT
$102B
| $273K | 0.1% |
555
+1
| +0.2% | +$468 |
2026 Q1
1 quarter
|
|
Similar funds
MEPT
LGL Partners's Q2 2026 Portfolio in Review
As of Q2 2026, LGL Partners held 73 positions worth $273M, up 13% from $243M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
LGL Partners's Q2 2026 filing shows 7 new, 40 increased, 6 reduced and 11 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 825 shares worth $567K. The largest sale was Eli Lilly, an estimated $1.19M.
By sector, the portfolio is most concentrated in Miscellaneous at 97% of assets, up from 95% a quarter earlier, followed by Financials and Technology.
- LGL Partners's largest Q2 2026 buy was Vanguard S&P 500 ETF: 825 shares worth $567K.
- LGL Partners added most to iShares Expanded Tech-Software Sector ETF in Q2 2026, an estimated $418K increase.
- LGL Partners's biggest Q2 2026 reduction was Sabra Healthcare REIT, cutting an estimated $794K.
- LGL Partners fully exited Eli Lilly in Q2 2026, selling an estimated $1.19M.
- LGL Partners's ten largest holdings make up 80% of its $273M portfolio in Q2 2026.
- LGL Partners opened 7 new positions and closed 11 in Q2 2026.
- LGL Partners's portfolio value rose 13% quarter-over-quarter to $273M.
Based on LGL Partners's 13F filing for Q2 2026, filed 27 Jul 2026.